Diquafosol ophthalmic solution

diquafosol · Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Diquafosol ophthalmic solution, covering 2025-09-19 to 2025-09-19. Get the full timeline:

Most recent: Clinical Trial Update: 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis [Phase 3]